Merck's oncology program: 140 abstracts @ASCO 2019
New research from the company’s broad oncology clinical development program will be presented at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 31-June 4. More than 140 abstracts have been accepted evaluating Merck’s medicines – including KEYTRUDA